-39.9%
AXON vs MRNA
+945.0%
-984.9%
-51.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.8% | +13.1% | -11.3% | +1.2% |
| 7D | +0.2% | +20.6% | -20.4% | -0.6% |
| 30D | +3.0% | +27.1% | -24.1% | +1.7% |
| 3M | -30.1% | +353.4% | -383.5% | -37.9% |
| 6M | +7.7% | +446.3% | -438.5% | -6.6% |
| YTD | -25.3% | +776.2% | -801.5% | -43.0% |
| 1Y | -39.9% | +987.9% | -1,027.8% | -55.4% |
| All | -39.9% | +945.0% | -984.9% | -55.4% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling